Renal transplantation between siblings with unrecognized Fabry disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Transplantation Proceedings

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.transproceed.2012.10.024PMID 23375284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heptinstall's Pathology of the Kidney

  2014cited by this paper
• Cardiovascular manifestations of Fabry disease and the novel therapeutic strategies.

  2005cited by this paper
• Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study.

  2004cited by this paper
• Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function.

  2003cited by this paper
• Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.

  2003cited by this paper
• Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study

  2003cited by this paper
• Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy.

  2002cited by this paper
• Renal pathological changes in Fabry disease

  2001cited by this paper
• Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

  2001cited by this paper
• Safety and efficacy of recombinant human alpha-galactosidase a replacement therapy in Fabry's disease

  2001cited by this paper
• Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

  2001cited by this paper
• Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.

  2000cited by this paper
• An atypical variant of Fabry's disease in men with left ventricular hypertrophy

  1996cited by this paper
• An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

  1995cited by this paper
• Fabry disease: molecular genetics of the inherited nephropathy.

  1989cited by this paper
• Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation.

  1985cited by this paper
• Early renal changes in hemizygous and heterozygous patients with Fabry's disease.

  1978cited by this paper
• Ceramide trihexosidosis (fabry's disease) without skin lesions.

  1971cited by this paper

• Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study

  2025cites this paper
• A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease

  2021cites this paper
• Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease

  2020cites this paper
• A case of latent heterozygous Fabry disease in a female living kidney donor candidate

  2020cites this paper
• Screening for Fabry Disease in Kidney Transplant Recipients: Experience of a Multidisciplinary Team

  2020cites this paper
• Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients.

  2019cites this paper
• Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

  2018cites this paper
• [Case Report: A case of living-donor kidney transplantation from a heterozygote mother to a hemizygote son of Fabry disease diagnosed by donated allograft biopsy].

  2015cites this paper
• [Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases].

  2013cites this paper